Federated Hermes
OLMA icon

Federated Hermes’s Olema Pharmaceuticals OLMA Stock Holding History

Federated Hermes’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Buy
+14,086
New +$314K ﹤0.01% 1483
2025
Q1 		– Sell
-150
Closed -$875 – 2158
2024
Q4 		$875 Buy
+150
New +$1.5K ﹤0.01% 2025
2023
Q4 		– Sell
-1,035
Closed -$12.8K – 2160
2023
Q3 		$12.8K Sell
1,035
-297
-22% -$3.03K ﹤0.01% 1802
2023
Q2 		$12K Sell
1,332
-377
-22% -$2.28K ﹤0.01% 1831
2023
Q1 		$5.93K Sell
1,709
-1,865
-52% -$7.61K ﹤0.01% 1917
2022
Q4 		$8.76K Buy
3,574
+673
+23% +$1.96K ﹤0.01% 1881
2022
Q3 		$8K Sell
2,901
-1,664
-36% -$7.06K ﹤0.01% 1855
2022
Q2 		$19K Buy
4,565
+2,105
+86% +$6.68K ﹤0.01% 1775
2022
Q1 		$10K Buy
2,460
+2,355
+2,243% +$13K ﹤0.01% 1887
2021
Q4 		$1K Sell
105
-259,895
-100% -$5.38M ﹤0.01% 2133
2021
Q3 		$7.17M Hold
260,000
– – 0.01% 738
2021
Q2 		$7.28M Hold
260,000
– – 0.01% 744
2021
Q1 		$8.63M Hold
260,000
– – 0.02% 710
2020
Q4 		$12.5M Buy
+260,000
New +$12.2M 0.03% 584

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Federated Hermes's OLMA Position: Q1 2026 in Review

Federated Hermes opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 14,086 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #1483 among its holdings. This is a return to the name: Federated Hermes previously reported a position in OLMA as recently as Q4 2024.

Federated Hermes first reported a position in OLMA in Q4 2020 and has held it in 14 quarters since. The position peaked at $12.5M in Q4 2020. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Federated Hermes held 14,086 shares of Olema Pharmaceuticals worth $210K as of Q1 2026.
  • Olema Pharmaceuticals was a new Federated Hermes position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1483 holding.
  • Federated Hermes first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 14 quarters since.
  • Federated Hermes's Olema Pharmaceuticals position peaked at $12.5M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.